CPIX
Cumberland Pharmaceuticals Inc
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
Cumberland Pharmaceuticals Inc
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
No thesis.
Cumberland Pharmaceuticals Inc
4.62
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | Ikarian CapitalIkarian Capital | $3.3M | 17.80% | −9.04% | |
| 2 | Renaissance TechnologiesRenaissance Technologies | $3.1M | 16.92% | +1.61% | |
| 3 | Vanguard Capital ManagementVanguardindex-like | $2.5M | 13.42% | +4.90% | |
| 4 | Susquehanna International GroupSusquehanna International | $1.8M | 9.92% | +281.50% | |
| 5 | Dimensional Fund AdvisorsDimensional | $1.5M | 8.25% | −15.58% | |
| 6 | Boothbay Fund ManagementBoothbay Fund | $729,285 | 3.98% | −11.86% | |
| 7 | Jane Street GroupJane Street | $723,434 | 3.95% | +89.52% | |
| 8 | Geode Capital ManagementGeodeindex-like | $702,616 | 3.84% | −5.14% | |
| 9 | Perceptive AdvisorsPerceptive | $628,443 | 3.43% | −50.77% | |
| 10 | Citadel AdvisorsCitadel | $625,262 | 3.41% | +93.98% | |
| 11 | BlackRockBlackRockindex-like | $411,785 | 2.25% | +11.70% | |
| 12 | Bank of New York MellonBank of New York Mellonindex-like | $378,807 | 2.07% | 0.00% | |
| 13 | Vanguard Fiduciary TrustVanguard Fiduciary Trustindex-like | $355,810 | 1.94% | +20.35% | |
| 14 | State StreetState Streetindex-like | $256,025 | 1.40% | 0.00% | |
| 15 | UBS GroupUBS | $170,677 | 0.93% | +407.59% | |
| 16 | Bridgeway Capital ManagementBridgeway | $169,776 | 0.93% | −83.97% | |
| 17 | BailardBailard | $159,564 | 0.87% | new | |
| 18 | Quadrature CapitalQuadrature Capital | $155,611 | 0.85% | new | |
| 19 | Two Sigma InvestmentsTwo Sigma | $155,397 | 0.85% | +116.34% | |
| 20 | Northern TrustNorthern Trustindex-like | $142,255 | 0.78% | +11.99% | |
| 21 | Arrowstreet Capital, Limited PartnershipArrowstreet Capital, Limited Partnership | $131,233 | 0.72% | 0.00% | |
| 22 | Cresset Asset ManagementCresset | $126,198 | 0.69% | 0.00% | |
| 23 | XTX TopcoXTX Topco | $91,485 | 0.50% | −41.19% | |
| 24 | Simplex TradingSimplex Trading | $29,445 | 0.16% | new | |
| 25 | Morgan StanleyMorgan Stanley | $21,131 | 0.12% | +0.03% |
33 managers report $18.3M of Cumberland Pharmaceuticals on form 13F for the quarter ended Jun 30 '26. 9 of them hold 80% of it; Ikarian Capital is largest at 17.80%.
Expected move
Inputsspot 4.69exp Nov 20ATM strike 5ATM straddle 1.48IV 157%